Table 1 Baseline characteristics in patients with HTG-APP (n = 45)
From: Role of mean platelet volume in hypertriglyceridemia-induced acute pancreatitis during pregnancy
Variables | Value | |
|---|---|---|
During in ICU (days) | 5.36 ± 4.18 | |
Ranson score, median (range) | 1 (0–3) | |
Trimester (n, %) | ||
First | 3 (6.7%) | |
Second | 11 (24.4%) | |
Third | 31 (68.9%) | |
Comorbidity (n, %) | ||
Fatty liver | 11 (24.4%) | |
Gestational diabetes mellitus | 5 (11.1%) | |
Pregnancy-induced hypertension | 2 (4.4%) | |
Local complications (n, %) | ||
Acute necrotic collections | 6 (13.3%) | |
Walled-off pancreatic necrosis | 14 (31.1%) | |
Acute peripancreatic fluid collections | 1 (2.2%) | |
Pancreatic pseudocyst | 8 (17.8%) | |
Systemic complications (n, %) | ||
Circulatory failure | 5 (11.1%) | |
Respiratory failure | 12 (26.7%) | |
Renal failure | 4 (8.9%) | |
Ketoacidosis | 8 (17.8%) | |
Mortality (n, %) | ||
Mother | 1 (2.2%) | |
Foetus | 6 (13.3%) | |
Treatment (n, %) | ||
Plasma exchange | 32 (71.1%) | |
Intubation | 16 (35.6%) | |
Abdominal paracentesis drainage | 14 (31.1%) | |
Conservative treatment | 11 (24.4%) | |